Great news!!! Initial $1.5 mil contract with DOD. The AutovaxId bioreactor provides opportunities for revenues independent of the lymphoma vaccine. The military, universities, WHO, and other companies trying to develope different vaccines. Looks like a very profitable business model.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.